25 research outputs found
Localization of <i>M</i>. <i>ulcerans</i> samples in French Guiana.
<p>In bold isolates belonging to genotype II.</p
Sequence variation of tandem repeat units.
<p>Dashes indicate a base deletion, and dots indicate an identical base compared to the reference sequence. Letters on the left indicate allele sequence codes.</p
Characteristics of <i>M</i>. <i>ulcerans</i> samples used in this study and sequence types based on sequence variations of tandem repeat units.
<p>VNTR, Variable Number Tandem Repeat; MIRU, Mycobacterial Interspersed Repetitive Unit; FG, French Guiana;</p><p>* DNA purified from culture; in bold results obtained after PCR and sequencing without needing nested PCR</p><p>Characteristics of <i>M</i>. <i>ulcerans</i> samples used in this study and sequence types based on sequence variations of tandem repeat units.</p
UPGMA phylogenetic tree.
<p>The analysis is based on amplicons size of VNTR18 and VNTR19 makers, and tandem repeats number for MIRU5, MIRU33 and SSR; FG, French Guiana; DRC, Democratic Republic of Congo; PNG, Papua New Guinea.</p
Primer sequence for each VNTR marker amplified by nested PCR.
<p>Primer sequence for each VNTR marker amplified by nested PCR.</p
Study of the SD Malaria Ag P.f/pan® performances compared to microscopy as gold standard, French Guiana, July 2010–July 2011.
<p>Entirely concordant results are shown in the grey fields.</p
Sequence of <i>P. falciparum</i> histidine-rich protein 2 (PfHRP<sub>2</sub>) exon 2 of isolates from French Guiana, 2010.
<p>Repeated sequences were encoded using codes previously published by Baker <i>et al</i>., 2005 <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0074269#pone.0074269-Baker1" target="_blank">[9]</a>.</p
Map of French Guiana, part of Amazonia, South America. Figures in brackets are the number of isolates collected in each health care institution then analysed retrospectively to evaluate the prevalence of <i>pfhrp2</i> deletion in French Guiana.
<p>Map of French Guiana, part of Amazonia, South America. Figures in brackets are the number of isolates collected in each health care institution then analysed retrospectively to evaluate the prevalence of <i>pfhrp2</i> deletion in French Guiana.</p
MOESM5 of A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants
Additional file 5. Overall clinical performances of the K13 reference assay obtained from 642 DBS collected from P. falciparum symptomatic patients in Cambodia, Myanmar and Africa and P. falciparum asymptomatic individuals in Cambodia. Cells coloured in green present concordant data obtained between the K13 bMx prototype assay and the K13 reference assay; Cells coloured in pale red present discordant data obtained between the K13 bMx prototype assay and the K13 reference assay